This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
By: MJ Alonso Lab
María José Alonso receives the prestigious ‘Distinguished Service Award’ and the ‘Women in Science Award’ of Controlled Release Society (CRS)
June 29, 2020These are new recognitions of the outstanding career of Professor Alonso by international scientific institutions, after her election to the US National Academy of Medicine, to the prestigious College of Fellows of the American Institute for Medical and Biological Engineering’s (AIMBE) and to the CRS College of Fellows. Alonso also received the “CRS Founders Award” granted by this scientific organization in 2018
Read More
Polyaminoacid-based nanocarriers: a review of the latest candidates for oral drug delivery
June 22, 2020In this review, we present an update of the current approaches and strategies carried out in the design of nanosystems and penetration-enhancing oral delivery strategies based on polyaminoacids.
Read More
María José Alonso leads a USC project aimed at developing a new vaccine against COVID-19 based on mRNA
May 11, 2020Developing and evaluating in preclinical studies a new vaccine based on mRNA against SARS-CoV2 capable of inducing long-term immune responses against the virus is the ultimate goal of the research project in which the laboratory led by María José Alonso participates together with the group led by Mabel Loza, both at CiMUS and FIDIS – University of Santiago de Compostela (USC). The objective of the USC laboratories is to produce a synthetic vehicle based on innocuous biomaterials, capable of transporting the mRNA into the target cells and enabling the production of the antigen in the human body.
Read More
María José Alonso, on ‘The Power List’ of the most influential researchers in the field of Biopharmaceuticals
April 23, 2020Professor Alonso is the only Spanish scientist in this ranking published by the magazine ‘The Medicine Maker’. This ranking highlights the career of the 60 most outstanding researchers worldwide in the areas of Small Molecules, Biopharmaceuticals, and Advanced Medicine
Read More
Get free access to our paper: “mRNA-activated matrices encoding transcription factors as primers of cell differentiation in tissue engineering”
April 22, 2020Publication: Adriana M. Ledo, Ana Senra, Héctor Rilo-Álvarez, Erea Borrajo, Anxo Vidal, María J. Alonso, Marcos García-Fuentes, RNA-activated matrices encoding transcription factors as primers of cell differentiation in tissue engineering, Biomaterials, Vol. 247, July 2020 https://doi.org/10.1016/j.biomaterials.2020.120016. Free Access until May 26
Read More
The Controlled Release Society doubly awarded the prestigious ‘Distinguished Service Award’ and the ‘Women in Science Award’ to María José Alonso
March 4, 2020These are new recognitions of the outstanding career of Professor Alonso by international scientific institutions, after her election to the US National Academy of Medicine, to the prestigious College of Fellows of the American Institute for Medical and Biological Engineering’s (AIMBE) and to the CRS College of Fellows.
Read More
Our latest paper, published in Drug Delivery and Translational Research: “Technological challenges in the preclinical development of an HIV nanovaccine candidate”
February 28, 2020In the obstacle race to the market nanomedicines face multiple challenges. If you want to know how to address them, check our recent paper about “Technological challenges in the preclinical development of an HIV nanovaccine candidate”, which has been just published in the DDTR journal.
Read More
The 25th Anniversary of the Spanish-Portuguese Local Chapter of the Controlled Release Society is just there!
January 16, 2020It will be held in Santiago de Compostela, January 22-24, 2020. We count with the participation of two past presidents of the CRS, Sandy Florence and María J. Alonso (founder of the SPLC-CRS), two CRS Board members, Steve Little and Mark Prausnitz, and representatives from all CRS European Local Chapters. An industry panel will also discuss the industry perspective on Nanomedicine. It is an amazing program with 20 invited speakers that so far has attracted the attention of 200 participants.
Read More
Targeting neurodegenerative diseases with RNA interference through the nose?
January 2, 2020We describe how the physicochemical properties of polymeric nanocapsules have a tremendous impact in their capacity to disseminate and accumulate in the different subpopulations of immune cells in the lymph nodes.
Read More
Merry Christmas and a Happy New Year! Looking forward even greater advancements in sciences for a good health
December 19, 2019Merry Christmas to everyone! We wish you a fabulous and full of science 2020!
Read More